Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fi ...
SEATTLE-- (BUSINESS WIRE)-- Know Labs, Inc. (NYSE American: KNW) (the “Company”), an emerging developer of non-invasive medical diagnostic technology, today announced the pricing of a firm ...
SEATTLE, December 13, 2024 -- (BUSINESS WIRE)-- Know Labs, Inc. (NYSE American: KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced the pricing ...
SEATTLE, November 16, 2024--Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on ...
Know Labs, Inc., a leading developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment underwritten public offering of 13,250,000 units at a public ...
Know Labs, Inc., leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10- K for the year ended September 30, 2024 ...
Further information can be found in Know Labs, Inc.’s Form 8-K filing with the Securities and Exchange Commission expected on or about Monday, December 16, 2024.
Know Labs, Inc. misses on earnings expectations. Reported EPS is $-0.04 EPS, expectations were $-0.01. KNW isn’t one of the 30 most popular stocks among hedge funds at the end of the third ...
KNOW LABS, INC. 競合他社・同業他社分析 - Industrial Applications and Services セクター
Our AI model demonstrates 18% historical accuracy for KNW predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
VAR_0__株価予測に影響を与える要因は何か?
当社の分析では、KNOW LABS, INC.の財務指標、Industrial Applications and Servicesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。